Anibal Carlo

Anibal Carlo is a seasoned executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Corporate Vice President & General Manager at Novo Nordisk since January 2025, Anibal previously held the position of Vice President & General Manager at Catalent Pharma Solutions, leading significant operational enhancements. At Hikma Pharmaceuticals, Anibal played a pivotal role in developing the technology segment and managing extensive manufacturing operations. Anibal also transformed Bristol Myers Squibb's Biotechnology DP facility, earning multiple product approvals, and improved performance metrics in Pfizer's aseptic operations. Anibal Carlo holds a Bachelor of Science in Mechanical Engineering, Magna Cum Laude, from the University of Puerto Rico-Mayaguez.